BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26797280)

  • 1. Re. "NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective".
    Toldo S; Marchetti C; Abbate A
    Biochem Biophys Res Commun; 2016 Feb; 470(4):811-2. PubMed ID: 26797280
    [No Abstract]   [Full Text] [Related]  

  • 2. NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective.
    Sandanger Ø; Gao E; Ranheim T; Bliksøen M; Kaasbøll OJ; Alfsnes K; Nymo SH; Rashidi A; Ohm IK; Attramadal H; Aukrust P; Vinge LE; Yndestad A
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1012-20. PubMed ID: 26706279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammasome activation in reperfusion injury: friendly fire on myocardial infarction?
    Grundmann S; Bode C; Moser M
    Circulation; 2011 Feb; 123(6):574-6. PubMed ID: 21282497
    [No Abstract]   [Full Text] [Related]  

  • 4. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury.
    Liu Y; Lian K; Zhang L; Wang R; Yi F; Gao C; Xin C; Zhu D; Li Y; Yan W; Xiong L; Gao E; Wang H; Tao L
    Basic Res Cardiol; 2014; 109(5):415. PubMed ID: 25015733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
    Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
    Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial control of the NLRP3 inflammasome.
    Kepp O; Galluzzi L; Kroemer G
    Nat Immunol; 2011 Mar; 12(3):199-200. PubMed ID: 21321591
    [No Abstract]   [Full Text] [Related]  

  • 7. Ghrelin protects the heart against ischemia/reperfusion injury via inhibition of TLR4/NLRP3 inflammasome pathway.
    Wang Q; Lin P; Li P; Feng L; Ren Q; Xie X; Xu J
    Life Sci; 2017 Oct; 186():50-58. PubMed ID: 28782532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of adaptive immunity by the NLRP3 inflammasome.
    Chen M; Wang H; Chen W; Meng G
    Int Immunopharmacol; 2011 May; 11(5):549-54. PubMed ID: 21118671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice.
    Mastrocola R; Collino M; Penna C; Nigro D; Chiazza F; Fracasso V; Tullio F; Alloatti G; Pagliaro P; Aragno M
    Oxid Med Cell Longev; 2016; 2016():3480637. PubMed ID: 26788246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway.
    Dong W; Yang R; Yang J; Yang J; Ding J; Wu H; Zhang J
    Int J Clin Exp Pathol; 2015; 8(8):8731-41. PubMed ID: 26464617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways.
    Mastrocola R; Penna C; Tullio F; Femminò S; Nigro D; Chiazza F; Serpe L; Collotta D; Alloatti G; Cocco M; Bertinaria M; Pagliaro P; Aragno M; Collino M
    Oxid Med Cell Longev; 2016; 2016():5271251. PubMed ID: 28053692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. shRNA interference of NLRP3 inflammasome alleviate ischemia reperfusion-induced myocardial damage through autophagy activation.
    Meng Z; Song MY; Li CF; Zhao JQ
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):728-735. PubMed ID: 29069583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nucleotide-binding domain, leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate, but not adaptive, immune responses after exposure to particulate matter under 10 μm.
    Hirota JA; Gold MJ; Hiebert PR; Parkinson LG; Wee T; Smith D; Hansbro PM; Carlsten C; VanEeden S; Sin DD; McNagny KM; Knight DA
    Am J Respir Cell Mol Biol; 2015 Jan; 52(1):96-105. PubMed ID: 24988285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to letter from Toldo et al. on "NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective".
    Yndestad A; Sandanger Ø; Jong WMC; Aukrust P; Zuurbier CJ
    Biochem Biophys Res Commun; 2016 May; 474(2):328-329. PubMed ID: 27109473
    [No Abstract]   [Full Text] [Related]  

  • 15. NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats.
    Qiu Z; Lei S; Zhao B; Wu Y; Su W; Liu M; Meng Q; Zhou B; Leng Y; Xia ZY
    Oxid Med Cell Longev; 2017; 2017():9743280. PubMed ID: 29062465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of umbelliferone ameliorates myocardial injury following ischemia‑reperfusion in the rat through suppression NLRP3 inflammasome and upregulating the PPAR-γ.
    Luo H; Fan Z; Xiang D; Jiang Z; Zhang W; Gao L; Feng C
    Mol Med Rep; 2018 Feb; 17(2):3404-3410. PubMed ID: 29257247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
    Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
    J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation and perpetuation of NLRP3 inflammasome activation and assembly.
    Elliott EI; Sutterwala FS
    Immunol Rev; 2015 May; 265(1):35-52. PubMed ID: 25879282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 regulates neutrophil functions and contributes to hepatic ischemia-reperfusion injury independently of inflammasomes.
    Inoue Y; Shirasuna K; Kimura H; Usui F; Kawashima A; Karasawa T; Tago K; Dezaki K; Nishimura S; Sagara J; Noda T; Iwakura Y; Tsutsui H; Taniguchi S; Yanagisawa K; Yada T; Yasuda Y; Takahashi M
    J Immunol; 2014 May; 192(9):4342-51. PubMed ID: 24696236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylsulfonylmethane inhibits NLRP3 inflammasome activation.
    Ahn H; Kim J; Lee MJ; Kim YJ; Cho YW; Lee GS
    Cytokine; 2015 Feb; 71(2):223-31. PubMed ID: 25461402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.